Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFin in advanced colorectal or breast cancer
NCT00026117Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2001
- Primary completion
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) and breast cancer comparing BeneFin with Placebo (2 arms). Primary endpoint: Overall Survival at 5 years. Started Aug 2001; status: completed.
02
Drugs
shark cartilage
03
Conditions
colorectal cancer (CRC)breast cancer
Beyond the preview
Go deeper on NCT00026117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026117.